This trial has been completed.

Condition osteoarthritis, avascular necrosis, rheumatoid arthritis, post-traumatic arthritis
Sponsor Orthosensor, Inc.
Start date October 2011
End date December 2016
Trial size 285 participants
Trial identifier NCT01469299, 1-Anderson


The primary objectives of this evaluation are: 1) To attempt to refine the current clinical understanding of "balance" 2) To determine if patients with quantifiably balanced knee joints exhibit improved clinical outcomes versus patient with residual imbalance, as measured by the VERASENSE™ Knee System

Secondary objectives:

- Determine whether a difference in inter-compartment loads and soft tissue tension exists between the physicians intra-operative feel compared to the quantifiable data measured by the VERASENSE™ Knee System

- Determine which ligament releases are performed by the surgeon to improve soft tissue balance while utilizing the information from the VERASENSE™ Knee System

- Evaluate range of motion, pain, physical function, activity level, and patient satisfaction between baseline (pre-operative) and post-operative follow-up as well as radiographic success and survivorship of the knee implants

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Joint Balance
time frame: At time of Total Knee Surgery

Secondary Outcomes

Patient Reported Outcome Measures
time frame: Changes from Baseline at 3-years

Eligibility Criteria

Male or female participants at least 50 years old.

Inclusion Criteria: - Subject must be a candidate for a primary total knee replacement - Subject must be diagnosed with one or more of the following conditions: osteoarthritis, avascular necrosis, rheumatoid or other inflammatory arthritis post-traumatic arthritis - Subject's joint must be anatomically and functionally suited to receive the selected implant - Subject is 50 years of age or older (≥ 50 yrs) at the time of consent - Subject is likely to be available for all study visits - Subject is able and willing to sign the informed consent and follow study procedures - Subject is not pregnant Exclusion Criteria: - Prior total knee arthroplasty - Subject has a mental condition that may interfere with the subject's ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the Subject cannot understand the informed consent process, global dementia, prior strokes that interfere with the Subject's cognitive abilities, senile dementia, and Alzheimer's Disease) - Subject is pregnant - Subject has an active infection or joint sepsis - Subject has muscular, neurological or vascular deficiencies which compromise the affected extremity (i.e., Parkinson's Disease, Multiple Sclerosis, and Charcot joints) - Ligament insufficiencies, prior surgeries such as ACL or PCL reconstructions, posterolateral reconstructions, osteotomies, tibia plateau fractures - Range of Motion less than 90 degrees, flexion contracture of more than 20 degrees

Additional Information

Official title Prospective Study Measuring Clinical Outcomes of Knee Arthroplasty Using the VERASENSE™ Knee System
Principal investigator Kenneth Gustke, MD
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by Orthosensor, Inc..